Has propranolol rendered sclerotherapy obsolete for poor risk alcoholic cirrhotic patients?
Kitano
S
S
Department of Surgery I, Oita Medical University, Japan.
D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000401:mortality / Q000628:therapy*; D011433:Propranolol / Q000627:therapeutic use*; D011446:Prospective Studies; D012008:Recurrence; D015911:Sclerotherapy; D012720:Severity of Illness Index
D011433:Propranolol